| Ytd | 4.39% | |
| 1y | 120.37% |
| Open | 1.20 | Prev Close | 1.20 | Low | 1.19 | High | 1.20 | Mkt Cap | 61.77M |
| Vol | 44.54K | Avg Vol | 328.82K | EPS | -0.23 | P/E | N/A | Forward P/E | -0.63 |
| Beta | 0.30 | Short Ratio | 0.85 | Inst. Own | 29.80% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-11 | 50-d Avg | 1.25 | 200-d Avg | 1.03 | 1yr Est | 4.17 |
TLPH News
Talphera, Inc. (TLPH) Q2 2026 Earnings Call Transcript
Talphera (NASDAQ:TLPH) reported quarterly losses of $(0.06) per share which beat the analyst consens
NEPHRO CRRT clinical study of nafamostat is 75% enrolled; expected to be complete this year Draft 20
SAN MATEO, Calif., Aug. 5, 2026 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a speci
HC Wainwright & Co. analyst Brandon Folkes assumes Talphera (NASDAQ:TLPH) with a Buy rating a
Talphera, Inc. (TLPH) Q1 2026 Earnings Call Transcript
Talphera (NASDAQ:TLPH) reported quarterly losses of $(0.04) per share which beat the analyst consens
NEPHRO CRRT clinical study expected to be completed this year Cash and investments of $21.1 million
SAN MATEO, Calif., May 7, 2026 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specia
WestPark Capital analyst Ed Arce initiates coverage on Talphera (NASDAQ:TLPH) with a Buy rating a
SAN MATEO, Calif., March 25, 2026 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a spe
Talphera (NASDAQ: TLPH) used a virtual analyst and investor event to provide a business update and t
Talphera, Inc. (TLPH) Analyst/Investor Day Transcript
Talphera (NASDAQ:TLPH) reported quarterly losses of $(0.06) per share which beat the analyst consens
Previously announced achievement of 50% enrollment of the NEPHRO CRRT clinical study in March 2026 a
SAN MATEO, Calif., March 18, 2026 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a spe
Enrolled 35 of the 70 patients in the ongoing NEPHRO-CRRT registrational study, supported by new tar
Enrolled 35 of the 70 patients in the ongoing NEPHRO-CRRT registrational study, supported by new tar
Talphera, Inc. (NASDAQ: TLPH - Get Free Report) insider Badri Dasu purchased 35,000 shares of the bu
Talphera, Inc. (NASDAQ: TLPH - Get Free Report) insider Shakil Aslam purchased 35,000 shares of the
Talphera, Inc. (NASDAQ: TLPH - Get Free Report) CFO Raffi Asadorian acquired 45,000 shares of the co
Talphera, Inc. (NASDAQ: TLPH - Get Free Report)'s share price fell 0.3% on Thursday. The company tra
Talphera, Inc. (NASDAQ: TLPH - Get Free Report)'s stock price fell 2.7% during trading on Monday. Th
Talphera, Inc. ( TLPH ) Q3 2025 Earnings Call November 12, 2025 4:30 PM EST Company Participants Raf
Talphera (NASDAQ:TLPH) reported quarterly losses of $(0.11) per share which beat the analyst consens
Closed $17 million first tranche financing led by a strategic investment from CorMedix, Inc. Cash an
SAN MATEO, Calif. , Nov. 5, 2025 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a spec
Talphera (NASDAQ:TLPH) reported quarterly losses of $(0.10) per share which beat the analyst consens
Talphera (NASDAQ:TLPH) reported quarterly losses of $(0.10) per share which beat the analyst consens